I'd like to know what we should watch for as people come before us with connections to drug companies, how we can identify them, and what we're likely to hear from them and how we should treat the evidence from these groups.
While you're at it, could both of you address the fact that there are a number of expert advisory committees to Health Canada with representatives of industry on them? What does this do to the work of these committees?